Agalsidase alfa (Replagal(™)) in the treatment of Anderson-Fabry disease

Anderson-Fabry disease (AFD) is an X-linked storage disorder caused by a deficiency of the lysosomal hydrolase a-galactosidase A (AGAL) and the resultant accumulation of its glycosphingolipid substrate (Gb3) in several tissue types. Major morbidity and reduced life expectancy among affected individu...

Descripción completa

Detalles Bibliográficos
Autor principal: Pastores, Gregory M
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721310/
https://www.ncbi.nlm.nih.gov/pubmed/19707338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721310/
https://www.ncbi.nlm.nih.gov/pubmed/19707338

Ejemplares similares